Who fares worse after liver transplantation? impact of donor and recipient variables on outcome: Data from a prospective study

Transplantation

Volumn 95, Issue 12, 2013, Pages 1528-1534

  Gambato, Martina ^a   Frigo, Anna C ^b   Castro, Kryssia I Rodríguez ^a   Senzolo, Marco ^a   Nadal, Elena ^a   D'Amico, Francesco ^a   Vitale, Alessandro ^a   Gringeri, Enrico ^a   Zanus, Giacomo ^a   Cillo, Umberto ^a   Russo, Francesco P ^a   Burra, Patrizia ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Donor criteria; Liver transplantation; Recipient features

Indexed keywords

BILIRUBIN;

ADOLESCENT; AGED; COLD ISCHEMIA; DISEASE ASSOCIATION; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; ORGAN DONOR; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BILIRUBIN; CARCINOMA, HEPATOCELLULAR; END STAGE LIVER DISEASE; FEMALE; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HUMANS; ISCHEMIA; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84880135378     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318292827f     Document Type: Review

References (30)

1. Burra P, Freeman R. Trends in liver transplantation 2011. J Hepatol 2012; 56: 101.
2. Freeman RB Jr. Model for End-Stage Liver Disease (MELD) for liver allocation: a 5-year score card. Hepatology 2008; 47: 1052.
3. Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130: 1652.
4. Yun BC, Kim WR, Benson JT, et al. Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology 2009; 49: 1610.
5. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783.
6. Halldorson JB, Bakthavatsalam R, Fix O, et al. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 2009; 9: 318.
7. Avolio AW, Cillo U, Salizzoni M, et al. Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. Am J Transplant 2011; 11: 2724.
8. Burra P, Porte RJ. Should donors and recipients be matched in liver transplantation? J Hepatol 2006; 45: 488.
9. Angelico M, Cillo U, Fagiuoli S, et al. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis 2011; 43: 155.
10. Cywinski JB, Mascha EJ, You J, et al. Pre-transplant MELD and sodium MELD scores are poor predictors of graft failure and mortality after liver transplantation. Hepatol Int 2011; 5: 841.
11. Brown RS Jr, Shiva Kumar K, Russo MW, et al. Model for End-Stage Liver Disease and Child-Turcotte-Pugh score as predictors of pre-transplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002; 8: 278.
12. Adler M, De Gendt E, Vereerstraeten P, et al. Value of the MELD score for the assessment of pre-and post-liver transplantation survival. Transplant Proc 2005; 37: 2863.
13. Kim DJ, Lee SK, Jo JW, et al. Prognosis after liver transplantation predicted by preoperative MELD score. Transplant Proc 2006; 38: 2095.
14. Young AL, Rajagenashan R, Asthana S, et al. The value of MELD and sodium in assessing potential liver transplant recipients in the United Kingdom. Transpl Int 2007; 20: 331.
15. Onaca NN, Levy MF, Sanchez EQ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003; 9: 117.
16. Weismüller TJ, Fikatas P, Schmidt J, et al. Multicentric evaluation of Model for End-Stage Liver Disease-based allocation and survival after liver transplantation in GermanyVlimitations of the 'sickest first'-concept. Transpl Int 2011; 24: 91.
17. Habib S, Berk B, Chang CC, et al. MELD and prediction of post-liver transplantation survival. Liver Transpl 2006; 12: 440.
18. Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004; 127: S261.
19. Vitale A, Ramirez Morales R, Dalla Bona E, et al. Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation. Transpl Proc 2011; 43: 974.
20. Wiesner RH, Sorrell M, Villamil F. Report of the first International Liver Transplant Society consensus conference on liver transplantation and hepatitis C. Liver Transpl 2003; 9: S1.
21. Rubín A, Aguilera V, Berenguer M. Liver transplantation and hepatitis C. Clin Res Hepatol Gastroenterol 2011; 35: 805.
22. Berenguer M, Prieto M, San Juan F, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36: 202.
23. Dawwas MF, Lewsey JD, Neuberger JM, et al. The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study. Liver Transpl 2007; 13: 1115.
24. Moore DE, Feurer ID, Speroff T, et al. Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg 2005; 140: 273.
25. Dutkowski P, Oberkofler CE, Slankamenac K, et al. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the Model for End-Stage Liver Disease era. Ann Surg 2011; 254: 745.
26. Desai NM, Mange KC, Crawford MD, et al. Predicting outcome after liver transplantation: utility of the Model for End-Stage Liver Disease and a newly derived discrimination function. Tr a n s p l a n t a t i o n 2004; 77: 99.
27. Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant 2004; 4: 308.
28. Cillo U, Vitale A, Grigoletto F, et al. Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria. Am J Transplant 2007; 7: 972.
29. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646.
30. Kamath PS, Wiesner RH, Malinchoc M, et al. Model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464.